HealthCo Healthcare and Wellness REIT unveils a mouth-watering $1.2bn deal
Nick Sundich, March 30, 2023
HealthCo Healthcare and Wellness REIT (ASX:HCW) has announced a $1.2bn deal to buy 11 private US hospitals from Medical Properties Trust (NYSE:MPW). The assets will be included in a new unlisted fund and may see HCW join the ASX 300.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
HealthCo Healthcare and Wellness REIT aspiring to grow in a tough period for REITs
It has been a difficult period for REITs as rising interest rates across the world hit the property market.
But evidently not all sectors have been as hard hit as others – the health sector has held strong given that it is critical infrastructure.
The properties were secured by HealthCo Healthcare and Wellness REIT at a purchase price representing an acquisition NOI yield of 5.8% and an unlevered IRR of >9%. The properties are leased at 16-year initial terms with 8 10 year options and CPI-linked rent increases.
Going for further growth
This deal brings HealthCo Healthcare and Wellness REIT’s Assets Under Management (AUM) to $7.5bn and it is aspiring to reach $10bn by the end of 2023.
It will be funded by a $125m capital raising and increased debt facilities, although it has promised to use $350m of its own cash.
HealthCo Healthcare and Wellness REIT’s reiterated its FY23 DPS guidance of 12c per share, representing an impressive 8.4% yield at yesterday’s closing price.
This deal could well see this REIT join the ASX 300 at the next index rebalancing, something which would trigger mandatory institutional buying of the stock.
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
There’s no credit card needed – the trial expires automatically.
Blog Categories
Recent Posts
Rule of 72: Here’s how investors can use it to their advantage
Here’s why The Rule of 72 might be useful to consider when investing in Stocks Investing in stocks can be…
Novo Nordisk (CPH: NOVO-B): It’s not all smooth sailing for the US$400bn company behind obesity drug Ozempic
Not many 100-year old healthcare stocks see a sudden 30% jump in sales in one year, but Novo Nordisk (CPH:…
Bapcor (ASX:BAP): Its been a horror week with a 3rd profit downgrade in less than a year
This week investors in Bapcor (ASX:BAP) saw a 3rd profit downgrade in less than a year and its CEO-elect walk…